Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2008
05/14/2008EP1920763A1 Pharmaceutical compositions for inhalation
05/14/2008EP1920370A2 Drug, drug guidance system, magnetic detection system, and drug design method
05/14/2008EP1920048A2 Gtpase inhibitors and methods of use and crystal structure of rac-1 gtpase
05/14/2008EP1919979A1 Polymer conjugates of k-252a and derivatives thereof
05/14/2008EP1919929A2 Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs
05/14/2008EP1919924A2 Compounds and compositions as protein kinase inhibitors
05/14/2008EP1919921A1 Bicyclic heterocycles as hiv integrase inhibitors
05/14/2008EP1919920A2 Pentacyclic kinase inhibitors
05/14/2008EP1919919A1 Pyridazinone derivatives used for the treatment of pain
05/14/2008EP1919916A1 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
05/14/2008EP1919914A2 P38 map kinase inhibitors and methods for using the same
05/14/2008EP1919913A2 P38 map kinase inhibitors and methods for using the same
05/14/2008EP1919911A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists
05/14/2008EP1919910A1 Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents
05/14/2008EP1919908A1 Triazole derivatives as modulators of dopamine d3 receptors
05/14/2008EP1919907A2 Heterocyclic compound
05/14/2008EP1919906A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
05/14/2008EP1919905A2 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-recptor tyrosine kinases
05/14/2008EP1919904A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919901A1 Substituted piperazines as metabotropic glutamate receptor antagonists
05/14/2008EP1919900A2 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
05/14/2008EP1919899A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919898A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919896A1 Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands.
05/14/2008EP1919895A2 2-aminoaryl pyridines as protein kinases inhibitors
05/14/2008EP1919894A2 Novel polyquinoline derivatives and the therapeutic use thereof
05/14/2008EP1919893A2 Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
05/14/2008EP1919891A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
05/14/2008EP1919890A1 Pyrazolone derivatives for the treatment of tuberculosis
05/14/2008EP1919884A1 N-benzyl-morpholine derivatives as modulators of the chemokine receptor
05/14/2008EP1919883A1 N-oxides as prodrugs of piperazine&piperidine derivatives
05/14/2008EP1919882A2 Isoxazole combretastatin derivatives for the treatment of proliferative disorders
05/14/2008EP1919881A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of poliferative disorders
05/14/2008EP1919879A1 9-aminocarbonylsubstituted derivatives of glycylcyclines
05/14/2008EP1919878A1 Pyridazinone derivatives as thyroid hormone receptor agonists
05/14/2008EP1919877A1 P38 map kinase inhibitors and methods for using the same
05/14/2008EP1919873A1 Fredericamycin derivatives
05/14/2008EP1919872A2 Chemical compounds
05/14/2008EP1919870A1 Ep2 receptor agonists for treating glaucoma
05/14/2008EP1919869A1 Novel indole compounds
05/14/2008EP1919868A2 New hybrid oligomers. their preparation process and pharmaceutical compositions containing them
05/14/2008EP1919865A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
05/14/2008EP1919863A1 Process for the production of bicalutamide
05/14/2008EP1919862A2 Novel sulfonamides
05/14/2008EP1919861A2 Compounds for treating alzheimer's disease
05/14/2008EP1919854A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
05/14/2008EP1919552A2 Regional therapies for treatment of pain
05/14/2008EP1919509A2 Highly cross-linked reagents for modifying biopharmaceuticals, production and use thereof
05/14/2008EP1919487A1 Particulate compositions comprising alginate and/or alginic acid
05/14/2008EP1919486A2 Core 2 glcnac-t inhibitors
05/14/2008EP1919485A1 Methods of preparing hetercyclic boronic acids and derivatives thereof
05/14/2008EP1919484A1 Use of dha in the form of phospholipids for the preparation of a composition that is intended for the treatment of respiratory failure
05/14/2008EP1919483A1 Combined preparation of a thiazide diuretic and a loop diuretic
05/14/2008EP1919482A1 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
05/14/2008EP1919481A2 Therapy for neurological diseases
05/14/2008EP1919480A2 Hedgehog pathway antagonists to treat disease
05/14/2008EP1919479A2 Melanocortin receptor-specific piperazine and keto-piperazine compounds
05/14/2008EP1919478A2 Combination of hcv protease inhibitors with a surfactant
05/14/2008EP1919477A1 Method of improving wakefulness
05/14/2008EP1919476A2 Benztropine compounds and uses thereof as dopamine uptake inhibitors
05/14/2008EP1919475A1 Tetrahydro- beta-carbolin-sulfonamide derivatives as 5-ht6 ligands
05/14/2008EP1919474A1 Pyrrolopyridine derivatives and use of same as ppar receptor modulators
05/14/2008EP1919473A1 Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use of same
05/14/2008EP1919472A1 Compositions and methods for treatment and prevention of hyperuricemia related health consequences
05/14/2008EP1919471A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
05/14/2008EP1919470A1 FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS
05/14/2008EP1919469A2 Process for preparing an angiotensin ii receptor antagonist
05/14/2008EP1919468A2 Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof
05/14/2008EP1919467A2 Duloxetine hydrochloride delayed release formulations
05/14/2008EP1919466A2 Formulations for treatment of lipoprotein abnormalities comprising a statin and a methylnicotinamide derivative
05/14/2008EP1919465A2 Gsk-3 inhibitors
05/14/2008EP1919464A1 Oxadiazole compounds as urokinase inhibitors
05/14/2008EP1919463A2 Use of hif 1alfa modulators for treatment of cancer
05/14/2008EP1919460A2 Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent
05/14/2008EP1919459A1 Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier
05/14/2008EP1919458A2 Enterically coated cysteamine, cystamine and derivatives thereof
05/14/2008EP1919457A2 Stable fixed-dose unitary formulation, containing tenofovir, a sufactant, efavirenz and emtricitabine
05/14/2008EP1919453A2 Processes for reducing particle size of aripiprazole
05/14/2008EP1919448A2 Vasoactive kit and composition and uses thereof
05/14/2008EP1919445A1 Controlled release of hypnotic agents
05/14/2008EP1919441A1 Substituted bicyclo [2.2.2]oct/5-ene compounds and their use as cooling agents
05/14/2008EP1919393A2 Drugs coated on a device to treat vulnerable plaque
05/14/2008EP1919304A1 Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain
05/14/2008EP1919300A1 Phosphorytated glucomannan polysaccharides containing 1-6 and 1-2 linkages increase weight gain in swine
05/14/2008EP1919290A2 Methods and products for treatment of diseases
05/14/2008EP1919288A2 Medicaments containing famotidine and ibuprofen and administration of same
05/14/2008EP1919287A2 Organic compounds for treating reduced dopamine receptor signalling activity
05/14/2008EP1919285A2 Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof
05/14/2008EP1806983B1 Nutritional and/or pharmaceutical preparation for use in prophylaxis and treatment of disturbances in microelements absorption from the alimentary canal
05/14/2008EP1771425B1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
05/14/2008EP1756064B1 Pyrazole derivatives, compositions containing such compounds and methods of use
05/14/2008EP1734922A4 Antimicrobial compositions
05/14/2008EP1723114B1 Biphenyl compounds useful as muscarinic receptor antagonists
05/14/2008EP1713776B1 Quinoline derivatives for use as mycobacterial inhibitors
05/14/2008EP1711468B1 Process for preparing purified ciprofloxacin
05/14/2008EP1696825A4 Use of alginate matrices to control cell growth
05/14/2008EP1689736A4 Biocidal siloxane coating material containing n-halogenated amine and amide functional groups
05/14/2008EP1667991B1 Quinazoline derivatives as tyrosine kinase inhibitors
05/14/2008EP1664013B1 Calcilytic compounds
05/14/2008EP1660184A4 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
1 ... 3265 3266 3267 3268 3269 3270 3271 3272 3273 3274 3275 3276 3277 3278 3279 3280 3281 3282 3283 3284 3285 ... 7860